BPC 157: Miracle Healing Peptide or Hidden Danger? Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options